Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Nightingale Health Plc Press release 7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulato ...

The executive order could come as soon as next week, if the Trump administration goes ahead with plans, according to people ...

Government Initiatives and Expanding Access to Medication-Assisted Treatment (MAT) Drive Growth in Opioid Use Disorder (OUD) MarketAustin, United States, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opioid Use ...

AttoSure, a premier drug and alcohol testing laboratory serving workplaces and healthcare institutions across the UK, proudly announces its recent achievements in securing certification to ISO 27001 ...

The physicians’ advocacy group Doctors for America is suing federal agencies for removing information from their websites ...

A new watchdog report highlights the ongoing issues concerning the oversight of foodborne illness in the United States and stresses the need for a national food ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

President Trump’s tariffs on Canada, China and Mexico could upend U.S. trade. These nine charts show what’s at stake, what ...